The FDA accepted octreotide (Mycapssa) capsules for lengthy-interval of time upkeep of acromegaly in those already handled with octreotide or lanreotide, Chiasma announced. Decided remedy…
The FDA accepted octreotide (Mycapssa) capsules for lengthy-interval of time upkeep of acromegaly in those already handled with octreotide or lanreotide, Chiasma announced. Decided remedy…